effects [qlco]
Transdermal [ftcn]
Oral [spco]
Therapies, Hormone Replacement [topp]
Monocyte Chemoattractant Protein-1 [aapp, imft]
Levels [qlco]
Randomized Clinical Trial [inpr, resa]
objectives [inpr]
effects [qlco]
Oral [spco]
Transdermal [ftcn]
Therapies, Hormone Replacement [topp]
Levels [qlco]
CARDIOVASCULAR [bdsy]
Markers, Disease [idcn]
MCP1 [bpoc]
Post-menopausal Period [orgf]
Study Design [resa]
Six [qnco]
Health [idcn]
postmenopausal [tmco]
Women [popg]
Study [mnob]
Patients [podg]
Assigned [ftcn]
Receive [qlco]
Oral [spco]
Transdermal [ftcn]
Therapies, Hormone Replacement [topp]
months [tmco]
Group [idcn]
Received [qlco]
Continuous [idcn]
Combined [qlco]
Oral [spco]
Therapies, Hormone Replacement [topp]
Containing [ftcn]
mg% [qnco]
17 beta-Estradiol [horm, phsu, strd]
mg% [qnco]
Norethisterone acetate [horm, phsu, strd]
N NOS [aapp, imft]
Second [qnco]
Group [idcn]
Received [qlco]
Sequential [idcn]
Transdermal [ftcn]
Therapies, Hormone Replacement [topp]
Releasing [ftcn]
mU/g [qnco]
day twice [tmco]
Estradiol [horm, phsu, strd]
Alone [qnco]
days [tmco]
MU/day [qnco]
Estradiol 25 MG [clnd]
Plus [qlco]
Norethisterone acetate [horm, phsu, strd]
GIVEN [cnce]
Twice [inpr]
days [tmco]
N NOS [aapp, imft]
Circulating [ftcn]
MCP1 [bpoc]
homocysteine [aapp, bacs]
CARDIOVASCULAR [bdsy]
Markers, Disease [idcn]
Assessed [acty]
treatment [ftcn]
Patients [podg]
baseline [bodm]
Characteristics [qlco]
Group [idcn]
baseline [bodm]
MCP1 [bpoc]
Levels [qlco]
Oral [spco]
Transdermal [ftcn]
Therapies, Hormone Replacement [topp]
Group [idcn]
pg/mL [qnco]
P NOS [aapp, imft]
MCP1 [bpoc]
Levels [qlco]
months [tmco]
Therapies, Hormone Replacement [topp]
Oral [spco]
pg/mL [qnco]
P NOS [aapp, imft]
Transdermal [ftcn]
Therapies, Hormone Replacement [topp]
Group [idcn]
pg/mL [qnco]
P NOS [aapp, imft]
Group [idcn]
MCP1 [bpoc]
months [tmco]
Therapies, Hormone Replacement [topp]
Levels [qlco]
Following [tmco]
months [tmco]
Therapies, Hormone Replacement [topp]
Conclusions [idcn]
Oral [spco]
Continuous [idcn]
Sequential [idcn]
Transdermal [ftcn]
HRT [topp]
effects [qlco]
MCP1 [bpoc]
Levels [qlco]
Women [popg]
Post-menopausal Period [orgf]
Ireland [geoa]
LTD [ortf]
Reserve [acty]
